Clinical Trial

TAF in Early/Middle Pregnancy With CHB

Name: TAF in Early/Middle Pregnancy With CHB — clinical trial record (NCT07668934)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: TAF;CHB

Enrolling by Invitation Phase 4

View on ClinicalTrials.gov →

Summary

The goal of this clinical trial is to study the efficacy and safety of Tenofovir alafenamide (TAF) vs Tenofovir disoproxil fumarate(TDF) in early and middle pregnancy with chronic hepatitis B.

Trial Details

NCT Number	NCT07668934
Lead Sponsor	The Third Affiliated Hospital of Guangzhou Medical University Collaborators: Second Affiliated Hospital of Guangzhou Medical University, Qingyuan People's Hospital
Conditions	Hepatitis B Infection, Pregnant Women, Early Pregnancy
Enrollment	816 participants
Start Date	2025-03-31
Primary Completion	2027-03-30 (estimated)
Study Completion	2028-03-30 (estimated)
Updated on ClinicalTrials.gov	2026-06-25